Cargando…

136 Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia

BACKGROUND: X-linked agammaglobulinemia (XLA) is characterized by impaired B-cell differentiation caused by mutations in Bruton's tyrosine kinase (Btk) gen. Btk is expressed in myeloid cells and recent evidence support that it participates in Toll like receptor signaling, but results regarding...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez Serrano, Maria Edith, Herrera, Gabriela López, Berrón-Ruiz, Laura, Estrada García, Iris Citlali, Martínez, Dolores Mogica, Espinosa, Sara, Marco Antonio, Yamazaki-Nakashimada, Garay, Alejandro González, Hernández, Alexander Vargas, Argumedo, Leopoldo Santos, Estrada Parra, Sergio Antonio, Espinosa Rosales, Francisco Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512689/
http://dx.doi.org/10.1097/01.WOX.0000411881.14030.7d
_version_ 1782251778869297152
author Gonzalez Serrano, Maria Edith
Herrera, Gabriela López
Berrón-Ruiz, Laura
Estrada García, Iris Citlali
Martínez, Dolores Mogica
Espinosa, Sara
Marco Antonio, Yamazaki-Nakashimada
Garay, Alejandro González
Hernández, Alexander Vargas
Argumedo, Leopoldo Santos
Estrada Parra, Sergio Antonio
Espinosa Rosales, Francisco Javier
author_facet Gonzalez Serrano, Maria Edith
Herrera, Gabriela López
Berrón-Ruiz, Laura
Estrada García, Iris Citlali
Martínez, Dolores Mogica
Espinosa, Sara
Marco Antonio, Yamazaki-Nakashimada
Garay, Alejandro González
Hernández, Alexander Vargas
Argumedo, Leopoldo Santos
Estrada Parra, Sergio Antonio
Espinosa Rosales, Francisco Javier
author_sort Gonzalez Serrano, Maria Edith
collection PubMed
description BACKGROUND: X-linked agammaglobulinemia (XLA) is characterized by impaired B-cell differentiation caused by mutations in Bruton's tyrosine kinase (Btk) gen. Btk is expressed in myeloid cells and recent evidence support that it participates in Toll like receptor signaling, but results regarding its rol in XLA patients are contradictories. OBJECTIVE: To evaluate lipopolysaccharide (LPS)-induced pro-inflammatory cytokine response in peripheral blood mononuclear cells (PBMC) from XLA patients. METHODS: Thirteen patients with XLA were included in the study. PBMC LPS-induced TNF-α, IL-1β, IL-6, and IL-10 production was determined by ELISA and compared with that obtained from matched healthy controls. Cytokine production was correlated with the severity of the mutation, affected domain and clinical characteristics. RESULTS: In response to LPS, PBMC from XLA patients produced significantly higher amounts of pro-inflammatory cytokines and IL-10 compared with controls and this production is not influenced by the neither severity of mutation or the affected domain. PBMC from patients with a history of more hospital admissions before diagnosis and patients with lower expression of Btk in monocytes produced higher levels of TNF-α and IL-1β, respectively. PBMC from patients with lower IgA levels showed a higher production of TNF-α and IL-1β. Less severe (punctual) mutations in Btk gene were associated with higher IgG levels at diagnosis. CONCLUSIONS: Our results demonstrated a predominantly inflammatory response in XLA patients after LPS stimuli and suggest a TLR signaling dysregulation in absence of Btk. This response may be influenced by environmental factors.
format Online
Article
Text
id pubmed-3512689
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35126892012-12-21 136 Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia Gonzalez Serrano, Maria Edith Herrera, Gabriela López Berrón-Ruiz, Laura Estrada García, Iris Citlali Martínez, Dolores Mogica Espinosa, Sara Marco Antonio, Yamazaki-Nakashimada Garay, Alejandro González Hernández, Alexander Vargas Argumedo, Leopoldo Santos Estrada Parra, Sergio Antonio Espinosa Rosales, Francisco Javier World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: X-linked agammaglobulinemia (XLA) is characterized by impaired B-cell differentiation caused by mutations in Bruton's tyrosine kinase (Btk) gen. Btk is expressed in myeloid cells and recent evidence support that it participates in Toll like receptor signaling, but results regarding its rol in XLA patients are contradictories. OBJECTIVE: To evaluate lipopolysaccharide (LPS)-induced pro-inflammatory cytokine response in peripheral blood mononuclear cells (PBMC) from XLA patients. METHODS: Thirteen patients with XLA were included in the study. PBMC LPS-induced TNF-α, IL-1β, IL-6, and IL-10 production was determined by ELISA and compared with that obtained from matched healthy controls. Cytokine production was correlated with the severity of the mutation, affected domain and clinical characteristics. RESULTS: In response to LPS, PBMC from XLA patients produced significantly higher amounts of pro-inflammatory cytokines and IL-10 compared with controls and this production is not influenced by the neither severity of mutation or the affected domain. PBMC from patients with a history of more hospital admissions before diagnosis and patients with lower expression of Btk in monocytes produced higher levels of TNF-α and IL-1β, respectively. PBMC from patients with lower IgA levels showed a higher production of TNF-α and IL-1β. Less severe (punctual) mutations in Btk gene were associated with higher IgG levels at diagnosis. CONCLUSIONS: Our results demonstrated a predominantly inflammatory response in XLA patients after LPS stimuli and suggest a TLR signaling dysregulation in absence of Btk. This response may be influenced by environmental factors. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512689/ http://dx.doi.org/10.1097/01.WOX.0000411881.14030.7d Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Gonzalez Serrano, Maria Edith
Herrera, Gabriela López
Berrón-Ruiz, Laura
Estrada García, Iris Citlali
Martínez, Dolores Mogica
Espinosa, Sara
Marco Antonio, Yamazaki-Nakashimada
Garay, Alejandro González
Hernández, Alexander Vargas
Argumedo, Leopoldo Santos
Estrada Parra, Sergio Antonio
Espinosa Rosales, Francisco Javier
136 Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia
title 136 Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia
title_full 136 Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia
title_fullStr 136 Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia
title_full_unstemmed 136 Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia
title_short 136 Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-linked Agammaglobulinemia
title_sort 136 increased pro-inflammatory cytokine production after lipopolysaccharide stimulation in patients with x-linked agammaglobulinemia
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512689/
http://dx.doi.org/10.1097/01.WOX.0000411881.14030.7d
work_keys_str_mv AT gonzalezserranomariaedith 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT herreragabrielalopez 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT berronruizlaura 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT estradagarciairiscitlali 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT martinezdoloresmogica 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT espinosasara 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT marcoantonioyamazakinakashimada 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT garayalejandrogonzalez 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT hernandezalexandervargas 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT argumedoleopoldosantos 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT estradaparrasergioantonio 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia
AT espinosarosalesfranciscojavier 136increasedproinflammatorycytokineproductionafterlipopolysaccharidestimulationinpatientswithxlinkedagammaglobulinemia